Fulgent Genetics, Inc.·4

May 22, 4:45 PM ET

Nohaile Michael 4

4 · Fulgent Genetics, Inc. · Filed May 22, 2023

Insider Transaction Report

Form 4
Period: 2023-05-18
Transactions
  • Award

    Common Stock

    2023-05-18+2,5296,529 total
  • Award

    Stock Option (Right to Buy)

    2023-05-18+3,3803,380 total
    Exercise: $35.58Exp: 2033-05-17Common Stock (3,380 underlying)
Footnotes (2)
  • [F1]Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
  • [F2]The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION